Intra-Renal Delivery of Drugs Targeting Ischemia-Reperfusion Injury of the Kidney using Normothermic Machine Perfusion

Hameed, Ahmer; Rogers, Natasha M.; Pleass, Henry; Lü, Bo; Miraziz, Ray; Hawthorne, Wayne J.

doi:10.1097/01.tp.0000543660.39716.78

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An exciting process evolving in parallel to kidney preservation with HMP is NMP. Although clinical data on this frontier of kidney preservation is limited, what is available suggests that kidney NMP is safe and beneficial; Hameed et al conducted a meta‐analysis comparing outcomes of kidneys preserved with HMP or NMP to SCS in animal models and found that NMP preservation was associated with reduced markers of IRI and displayed superior long‐term performance compared to their HMP or SCS‐preserved counterparts 64 …”

Section: Clinical Data and Discussion: Kidneymentioning

confidence: 99%

Machine perfusion of donor organs for transplantation

et al. 2021

View full text Add to dashboard Cite

The ever‐widening gap between organ supply and demand has resulted in an organ shortage crisis that affects patients all over the world. For decades, static cold storage (SCS) was the gold standard preservation strategy because of its simplicity and cost‐effectiveness, but the rising unmet demand for donor organ transplants has prompted investigation into preservation strategies that can expand the available donor pool. Through ex vivo functional assessment of the organ prior to transplant, newer methods to preserve organs such as perfusion‐based therapy can potentially expand the available organ pool. This review will explain the physiologic rationale for SCS before exploring the advantages and disadvantages associated with the two broad classes of preservation strategies that have emerged to address the crisis: hypothermic and normothermic machine perfusion. A detailed analysis of how each preservation strategy works will be provided before investigating the current status of clinical data for each preservation strategy for the kidney, liver, pancreas, heart, and lung. For some organs there is robust data to support the use of machine perfusion technologies over SCS, and in others the data are less clear. Nonetheless, machine perfusion technologies represent an exciting frontier in organ preservation research and will remain a crucial component of closing the gap between organ supply and recipient demand.

show abstract

Section: Clinical Data and Discussion: Kidneymentioning

confidence: 99%

Machine perfusion of donor organs for transplantation

et al. 2021

View full text Add to dashboard Cite

show abstract

“…There was no albumin adsorption over 1 h (albumin concentrations at 0, 30, and 60 min of perfusion were 99, 97, and 102 g/l, respectively). We have successfully perfused 12 discarded human kidneys and 17 porcine kidneys using this set-up [7,8]. Each kidney had declining intra-renal resistance (IRR) and increasing flow, in addition to evidence of urine output.…”

mentioning

confidence: 99%